Answers are grounded in this paper and cite their sources.
Multi-center cohort study evaluates imaging biomarkers and clinical outcomes in MASLD, indicating future diagnostic potential.
GOLDMINE establishes a rigorously phenotyped MASLD cohort integrating centralized histology, advanced MRI-based biomarkers, longitudinal biobanking, and adjudicated outcomes, providing a platform to validate imaging and blood-based prognostic biomarkers in MASLD.
No takes yet. Share an insight, caveat, or question.
Sharpton et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: